News | March 20, 2025
Syngene concludes acquisition of biologics manufacturing facility from Emergent BioSolutions
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L
In 2023, Endox had revenues of approximately SEK 65 million
The transaction is part of a broader agreement with Bureau Veritas covering its worldwide food laboratory testing activities
Acquisition adds potential best-in-class disease-modifying therapy for Alzheimer's disease
Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.
The transaction involves the acquisition of 100% shareholding of Bharat Serums and Vaccines (BSV) by Mankind Pharma
The acquisition of LumiraDx’s Point of Care technology received all required antitrust and regulatory clearances
Emraclidine, a potential best-in-class, next-generation antipsychotic, is in trials designed to be registration enabling for schizophrenia
This transaction is the third acquisition by three different Japanese players in this segment
Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret
Subscribe To Our Newsletter & Stay Updated
